{"id":61355,"date":"2024-11-06T00:04:55","date_gmt":"2024-11-06T00:04:55","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/11\/06\/anaptys-announces-participation-in-november-and-december-investor-conferences\/"},"modified":"2024-11-06T00:04:55","modified_gmt":"2024-11-06T00:04:55","slug":"anaptys-announces-participation-in-november-and-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/","title":{"rendered":"Anaptys Announces Participation in November and December Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">SAN DIEGO, Nov.  05, 2024  (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its senior management team, are scheduled to participate in multiple upcoming investor conferences:<\/p>\n<p><strong>Guggenheim&#8217;s Inaugural Healthcare Innovation Conference<\/strong>, Boston, MA<\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, Nov. 13, 2024 at 1:30pm ET \/ 10:30am PT<\/li>\n<\/ul>\n<p><strong>Stifel 2024 Healthcare Conference, <\/strong>New York, NY<\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Tuesday, Nov. 19, 2024 at 1:50pm ET \/ 10:50am PT<\/li>\n<\/ul>\n<p><strong>Piper Sandler 36th Annual Healthcare Conference, <\/strong>New York, NY<\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Tuesday, Dec. 3, 2024 at 2:30pm ET \/ 11:30am PT<\/li>\n<\/ul>\n<p><strong>7th Annual Evercore HealthCONx Conference<\/strong>, Coral Gables, FL<\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, Dec. 4, 2024 at 1:45pm ET \/ 10:45am PT<\/li>\n<\/ul>\n<p>Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WtRROz3ak_bE3nkwyBKDOj89LNTeRc6DytyXHuJyBYSWqLn71MEwxmWWowz8YQ4yrmLXvMq_spwhhIjx2Nu5F5IvK3MJTZarFuiAEFenbCfQD2PFTg4XqrIavw71TvG0\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">http:\/\/ir.anaptysbio.com\/events<\/a>. Replays of the webcasts will be available for at least 30 days following the events.<\/p>\n<p><strong>About Anaptys<\/strong><\/p>\n<p>Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. Its pipeline includes two programs targeting co-inhibitory receptors: ANB032, its BTLA agonist, in a Phase 2b trial for the treatment of atopic dermatitis and rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis. It also has other antibodies in its portfolio, including ANB033, an anti-CD122 antagonist, in a Phase 1 trial and ANB101, a BDCA2 modulator, soon to enter clinical development. In addition, Anaptys has developed two cytokine antagonists available for out-licensing: imsidolimab, an anti-IL-36R antagonist, that has completed Phase 3 trials for the treatment of generalized pustular psoriasis, and etokimab, an anti-IL-33 antagonist that is Phase 2\/3 ready. Anaptys has also discovered multiple therapeutic antibodies licensed to GSK in a financial collaboration for immuno-oncology, including an anti-PD-1 antagonist (<em>Jemperli<\/em> (dostarlimab-gxly)) and an anti-TIM-3 antagonist (cobolimab, GSK4069889). To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JskFj5e8G8WOElQ6EdufNeu_4v8tTuHqLiZYrzNI2L905iWctIS267_X4aaKokMckT7DyWbPN3XP7TJkPgMBpGkILQXPV8gfTnJAk9y1cQU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.AnaptysBio.com\">www.AnaptysBio.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rldH4p6QMRjrq1YGxcJRA8bcs_vZqfCwMAgzZIDUKbgzFdHBR3DuLdQbAjqGaNIpTqkqwoE68oUqzpxyBbtLrJyofV-D_Oat2SWsy0UMxj0=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=czVskXGc_BalQfOar2_WBiIXSf_uKOQe_9OORW57FsdMf_pNtZqCmOtAc5kr-GDfjLaGYYT3ofllaKagHDT6RQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"X\">X<\/a>.<\/p>\n<p><strong>Contact:<\/strong><br \/>Nick Montemarano<br \/>Senior Director, Investor Relations and Strategic Communications <br \/>858.732.0178<br \/><u>investors@anaptysbio.com<\/u><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGJlMmE5Y2QtMjAyNC00NDI3LTg2NDctNzY0MTU4YmY0ZjgyLTEwMzE2OTg=\/tiny\/AnaptysBio-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and\/or other members of its senior management team, are scheduled to participate in multiple upcoming investor conferences: Guggenheim&#8217;s Inaugural Healthcare Innovation [&#8230;]\n","protected":false},"author":1,"featured_media":61356,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anaptys Announces Participation in November and December Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anaptys Announces Participation in November and December Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innova\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-06T00:04:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/AnaptysBio-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Anaptys Announces Participation in November and December Investor Conferences\",\"datePublished\":\"2024-11-06T00:04:55+00:00\",\"dateModified\":\"2024-11-06T00:04:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\",\"name\":\"Anaptys Announces Participation in November and December Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-11-06T00:04:55+00:00\",\"dateModified\":\"2024-11-06T00:04:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anaptys Announces Participation in November and December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Anaptys Announces Participation in November and December Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Anaptys Announces Participation in November and December Investor Conferences","og_description":"SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) &#8212; AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innova","og_url":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-11-06T00:04:55+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/AnaptysBio-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Anaptys Announces Participation in November and December Investor Conferences","datePublished":"2024-11-06T00:04:55+00:00","dateModified":"2024-11-06T00:04:55+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/"},"wordCount":382,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/","name":"Anaptys Announces Participation in November and December Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-11-06T00:04:55+00:00","dateModified":"2024-11-06T00:04:55+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/anaptys-announces-participation-in-november-and-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Anaptys Announces Participation in November and December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61355"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61355\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61356"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}